Brighton Jones LLC Regeneron Pharmaceuticals, Inc. Transaction History

Brighton Jones LLC

$2.55 Billion
Q3 2024

A detailed history of Brighton Jones LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Brighton Jones LLC holds 262 shares of REGN stock, worth $203,967. This represents 0.01% of its overall portfolio holdings.

Number of Shares

262

Previous 920 71.52%

Holding current value

$203,967

Previous $966,000 71.53%

% of portfolio

0.01%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$1024.09 - $1201.76 $673,851 - $790,758	-658 Reduced 71.52%	262 $275,000
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $12,364 - $14,996	14 Added 1.55%	920 $966,000
Q1 2024 May 09, 2024	SELL	$902.69 - $993.35 $29,788 - $32,780	-33 Reduced 3.51%	906 $872,000
Q4 2023 Feb 05, 2024	SELL	$775.18 - $881.7 $1,550 - $1,763	-2 Reduced 0.21%	939 $824,000
Q3 2023 Oct 25, 2023	BUY	$692.45 - $844.37 $37,392 - $45,595	54 Added 6.09%	941 $774,000
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $19,600 - $23,249	-28 Reduced 3.06%	887 $637,000
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $6,804 - $8,269	-10 Reduced 1.08%	915 $751,000
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $6,353 - $6,897	-9 Reduced 0.96%	925 $667,000
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $5,165 - $6,518	-9 Reduced 0.95%	934 $643,000
Q2 2022 Aug 04, 2022	SELL	$548.35 - $738.84 $32,352 - $43,591	-59 Reduced 5.89%	943 $557,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $114,263 - $134,098	192 Added 23.7%	1,002 $700,000
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $109,239 - $134,864	201 Added 33.0%	810 $512,000
Q3 2021 Nov 04, 2021	BUY	$574.03 - $680.96 $30,423 - $36,090	53 Added 9.53%	609 $369,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $34,987 - $41,331	74 Added 15.35%	556 $311,000
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $58,968 - $72,362	-132 Reduced 21.5%	482 $228,000
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $97,094 - $123,419	203 Added 49.39%	614 $297,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $223,892 - $270,524	411 New	411 $230,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Account

Brighton Jones LLC Regeneron Pharmaceuticals, Inc. Transaction History